LONDON, July 25, 2024 (GLOBE NEWSWIRE) -- Kaerus Bioscience Ltd. (www.kaerusbio.com), a clinical-stage biotechnology company focused on developing therapeutics for rare genetic syndromes of ...

NEW YORK, Oct. 26 Reportlinker.com announces that a new market research report is available in its catalogue. Ion channels represent a significant opportunity to address an underexploited class of ...

Praxis Precision Medicines has received Breakthrough Therapy Designation (BTD) from the FDA for relutrigine, a sodium channel modulator intended for pediatric treatment of SCN2A and SCN8A ...

CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biotechnology company developing novel therapeutics for neurological diseases, announced today that their first ...

Ion channel CRO Metrion Biosciences has reached a collaboration agreement with Venomtech to utilize the latter’s venom library in search of novel ion channel modulators. Through the deal, Metrion will ...

Bsense Bio Therapeutics Ltd. has nominated BSEN-760, a dual Kv7.2/3 and TRPV1 ion channel modulator, as a clinical candidate for the treatment of chronic pain.

The What Else: Channel Vision’s new 2-Channel, 1080p HDMI Modulator has a full set of features, including the full spectrum of TV channels on ATSC-antenna and QAM-64/256 for cable TV systems, MPEG, ...

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medixci for the development of therapeutics for rare genetic ...